Evidence map›Paper›PMID 30638292›Full record

ArticleProtein science : a publication of the Protein Society2019

Structure, function, and inhibition of a genomic/clinical variant of Porphyromonas gingivalis peptidylarginine deiminase.

Grzegorz Bereta, Theodoros Goulas, Mariusz Madej, Ewa Bielecka, Maria Solà, Jan Potempa, F Xavier Gomis-Rüth

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Pathogenicity ofFrontiers in cellular and infection microbiology · 2026
    Article
  4. Pathogenesis ofFrontiers in cellular and infection microbiology · 2026
    Review
  5. The Role ofCancers · 2025
    Review
  6. Review
  7. Polymorphic Variants of Peptidylarginine Deiminase Gene fromInternational journal of molecular sciences · 2025
    Article
  8. In Vitro Infection of Human Macrophages withInternational journal of molecular sciences · 2025
    Article
  9. Review
  10. Impact of increasedJournal of oral microbiology · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. TLR2 Activation byFrontiers in immunology · 2022
    Article
  15. Implications ofFrontiers in cellular and infection microbiology · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Peptidylarginine Deiminase ofInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Grzegorz BeretaDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, PL-30-387, Kraków, Poland.
Theodoros GoulasProteolysis Laboratory, Structural Biology Unit, Molecular Biology Institute of Barcelona, CSIC, Barcelona Science Park, Helix Building, c/Baldiri Reixac, 15-21, E-08028, Barcelona, Catalonia, Spain.
Mariusz MadejDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, PL-30-387, Kraków, Poland.
Ewa BieleckaMalopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7A, PL-30-387, Kraków, Poland.
Maria SolàStructural MitoLab, Structural Biology Unit, Molecular Biology Institute of Barcelona, CSIC, Barcelona Science Park, Helix Building, c/Baldiri Reixac, 15-21, E-08028, Barcelona, Catalonia, Spain.
Jan PotempaDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, PL-30-387, Kraków, Poland.
F Xavier Gomis-RüthProteolysis Laboratory, Structural Biology Unit, Molecular Biology Institute of Barcelona, CSIC, Barcelona Science Park, Helix Building, c/Baldiri Reixac, 15-21, E-08028, Barcelona, Catalonia, Spain.
Jagiellonian University · PLInstitut de Biologia Molecular de Barcelona · ES

Funding

Bacterial peptidylarginine deiminase, a link between gums and joint diseaseR01DE022597 · NIDCR · UNIVERSITY OF LOUISVILLE · PI POTEMPA, JAN S · 2013 to 2023
$3.7M
NIDCR NIH HHS R01 DE022597NIH HHS R01 DE022597
6 · The paper itself

Abstract

Citrullination is an essential post-translational modification in which the guanidinium group of protein and peptide arginines is deiminated by peptidylarginine deiminases (PADs). When deregulated, excessive citrullination leads to inflammation as in severe periodontal disease (PD) and rheumatoid arthritis (RA). Porphyromonas gingivalis is the major periodontopathogenic causative agent of PD and also an etiological agent of RA. It secretes a PAD, termed Porphyromonas PAD (PPAD), which is a virulence factor that causes aberrant citrullination. Analysis of P. gingivalis genomes of laboratory strains and clinical isolates unveiled a PPAD variant (PPAD-T2), which showed three amino-acid substitutions directly preceding catalytic Residue H

Indexed as

Amino Acid SubstitutionBacteroidaceae InfectionsCrystallography, X-RayEnzyme InhibitorsHumansModels, MolecularPorphyromonas gingivalisProtein-Arginine DeiminasesProtein ConformationEnzyme InhibitorsProtein-Arginine Deiminasesbacterial virulence factorcitrullinationperiodontal diseaserheumatoid arthritistarget-drug complexX-ray crystal structure

Identifiers

PMID30638292
PMCPMC6371208
OpenAlexW2910457436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.